The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aerovate Therapeutics, Inc. Common Stock 008064107 38,597 2,327,909 SH   SOLE   2,327,909 0 0
Akero Therapeutics, Inc. Common Stock 00973Y108 33,854 994,251 SH   SOLE   994,251 0 0
AvroBio, Inc. Common Stock 05455M100 2,905 4,520,863 SH   SOLE   4,520,863 0 0
Day One Biopharmaceuticals, Inc. Common Stock 23954D109 163,628 8,169,171 SH   SOLE   8,169,171 0 0
Dyne Therapeutics, Inc. Common Stock 26818M108 113,473 8,934,902 SH   SOLE   8,934,902 0 0
F-star Therapeutics, Inc. Common Stock 30315R107 3,070 599,524 SH   SOLE   599,524 0 0
Gemini Therapeutics, Inc. Common Stock 36870G105 8,617 5,254,365 SH   SOLE   5,254,365 0 0
Generation Bio, Co. Common Stock 37148K100 43,961 8,278,876 SH   SOLE   8,278,876 0 0
Ikena Oncology, Inc. Common Stock 45175G108 17,815 5,018,178 SH   SOLE   5,018,178 0 0
Kymera Therapeutics, Inc. Common Stock 501575104 149,684 6,875,698 SH   SOLE   6,875,698 0 0
Magenta Therapeutics, Inc. Common Stock 55910K108 4,902 3,476,536 SH   SOLE   3,476,536 0 0
Replimune Group, Inc. Common Stock 76029N106 53,680 3,108,300 SH   SOLE   3,108,300 0 0
Spero Therapeutics, Inc. Common Stock 84833T103 2,062 1,031,160 SH   SOLE   1,031,160 0 0
Third Harmonic Bio, Inc. Common Stock 88427A107 206,922 10,907,859 SH   SOLE   10,907,859 0 0
Vigil Neuroscience, Inc. Common Stock 92673K108 53,116 5,836,874 SH   SOLE   5,836,874 0 0
Viridian Therapeutics, Inc. Common Stock 92790C104 1,847 90,072 SH   SOLE   90,072 0 0
Xilio Therapeutics, Inc. Common Stock 98422T100 8,030 2,759,344 SH   SOLE   2,759,344 0 0